Quick Takeaways
- Keith Crandell has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $108,781,985.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Keith Crandell
- Location
- Chicago, IL
- Summary
- The estimated net worth of Keith Crandell is at least $108,781,985 dollars as of 09 Feb 2026. Keith Crandell is the 10%+ Owner of Sana Biotechnology, Inc. and owns shares of Sana Biotechnology, Inc. (SANA) stock worth about $68.45M. Keith Crandell is the Director, 10%+ Owner of 908 Devices Inc. and owns shares of 908 Devices Inc. (MASS) stock worth about $26.74M. Keith Crandell is the Director, 10%+ Owner of DA32 Life Science Tech Acquisition Corp. and owns shares of DA32 Life Science Tech Acquisition Corp. stock worth about $6.5M. Keith Crandell is the Director of Twist Bioscience Corp and owns shares of Twist Bioscience Corp (TWST) stock worth about $3.56M. Keith Crandell is the Director of Quanterix Corp and owns shares of Quanterix Corp (QTRX) stock worth about $3.53M.
- Signature
- /s/ Kendra Fox, as Attorney-in-Fact for Keith Crandell
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Keith Crandell and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Sana Biotechnology, Inc. ($68,453,121).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Keith Crandell
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SANA | Sana Biotechnology, Inc. | 10%+ Owner | $68,453,121 | 08 Feb 2024 | ||
| MASS | 908 Devices Inc. | Director, 10%+ Owner | $26,739,062 | 11 Jun 2025 | ||
| DALS | DA32 Life Science Tech Acquisition Corp. | Director, 10%+ Owner | $6,500,000 | 28 Jul 2023 | ||
| TWST | Twist Bioscience Corp | Director | $3,558,241 | 05 Feb 2026 | ||
| QTRX | Quanterix Corp | Director | $3,531,561 | 03 Apr 2023 | ||
| BOLD | Boundless Bio, Inc. | 10%+ Owner | 02 Apr 2024 |
Insider Transactions Reported by Keith Crandell:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.